AI Summary7 Sept 202626 Rabiʻ I 1448 AH
AI Summary
7 Sept 202626 Rabiʻ I 1448 AH
AI-designed drug appears to turn back the body's biological clock in early trial
A study published in Nature Biotechnology indicates that rentosertib, an AI-designed drug by Insilico Medicine, may reverse biological aging markers.
Six independent aging clocks predicted that treated patients appeared biologically up to six years younger than those in the placebo group.
The trial involved only 42 patients, and the drug has yet to be tested on healthy individuals, raising questions about its broader efficacy.
Follow these topics
Sign in to follow the topics that matter to you
This summary is generated with AI and receives periodic editorial review. Refer to the original source for full details.
AI-designed drug appears to turn back the body's biological clock in early trial
A study published in Nature Biotechnology indicates that rentosertib, an AI-designed drug by Insilico Medicine, may reverse biological aging markers.
Six independent aging clocks predicted that treated patients appeared biologically up to six years younger than those in the placebo group.
The trial involved only 42 patients, and the drug has yet to be tested on healthy individuals, raising questions about its broader efficacy.
Models
Follow these topics
Sign in to follow the topics that matter to you
This summary is generated with AI and receives periodic editorial review. Refer to the original source for full details.
0
0 reading now
Insight Score
Rate to unlock
You have not rated yet.
Sign in to react, rate, and save. Sign In
